Intelecta (Levocarnitine)

Levocarnitine functions as a carrier molecule that transports long‑chain fatty acids across the inner mitochondrial membrane. This enables β‑oxidation, the process by which fatty acids are broken down to generate ATP, and also assists in removing excess acyl groups, thereby supporting normal cellular energy metabolism.

The appropriate dose of Intelecta is determined by the prescribing healthcare professional based on the patient’s age, weight, renal function and the specific indication. Dosage may vary widely, and patients should follow the prescriber’s instructions without self‑adjusting the amount.

Safety data for levocarnitine during pregnancy and lactation are limited. It should only be used when the potential benefit justifies any possible risk to the fetus or infant. Healthcare providers should evaluate each case individually and discuss potential risks with the patient.

To request Intelecta, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will ask for trade or institutional credentials. The team then replies with pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Intelecta provides levocarnitine, the biologically active form of carnitine, whereas some alternatives contain acetyl‑ or propionyl‑carnitine esters. Levocarnitine is directly utilized in the mitochondrial shuttle, offering efficient support of fatty‑acid oxidation. Choice of product may depend on formulation preferences, cost, and specific clinical guidance.

Intelecta should be stored at ambient temperature below 25 °C, in its original packaging, and protected from moisture and direct sunlight. Keeping the product in a dry, cool place helps maintain its stability and potency throughout its shelf life.

Intelecta is taken orally, usually as tablets or capsules, with or without food as directed by the prescriber. The patient should swallow the dosage form whole and avoid crushing or chewing unless specifically instructed.

Serious adverse reactions, although rare, include hypersensitivity or anaphylactic responses, severe skin rashes such as Stevens‑Johnson syndrome, cardiac arrhythmias, metabolic acidosis, and seizures. Patients should seek immediate medical attention if they experience any of these symptoms.

Individuals with a known hypersensitivity to levocarnitine or any excipients in the formulation should avoid Intelecta. Patients with severe renal impairment should use it only under close medical supervision, and those with a history of severe allergic reactions should discuss alternatives with their healthcare provider.